As an autosomal dominant condition, a child has a 50% chance of inheriting Huntington’s disease from a parent. Learn more about Brianna’s journey facing a future diagnosis of HD: https://lnkd.in/dp2qc3bt
Prilenia
生物技术研究
Boston，Massachusetts 6,816 位关注者
Dedicated to developing new treatments for neurodegenerative diseases and neurodevelopmental disorders.
关于我们
Prilenia is a clinical-stage biotech company focused on developing novel treatments for neurodegenerative and neurodevelopmental disorders. Our lead asset is Pridopidine, a first-in-class oral drug candidate with an established safety profile and potential in multiple movement disorders and neurodegenerative diseases affecting adults and children. Pridopidine is currently being evaluated for the treatment of Huntington’s disease in our global Phase 3 PROOF-HD trial, and for the treatment of ALS in the Phase 2/3 HEALEY platform trial. The company is led by Dr. Michael Hayden, MD, PhD, the founder of five biotech companies and previous President of Global R&D and Chief Scientific Officer at Teva. Michael has directed the development of multiple innovative drug products, leading to 35 approvals between 2012-2018. The Company is based in Naarden, the Netherlands, Herzliya, Israel and Boston, MA in the U.S.
- 网站
-
https://www.prilenia.com/
Prilenia的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Boston，Massachusetts
- 类型
- 私人持股
- 创立
- 2018
地点
Prilenia员工
动态
-
Prilenia转发了
Huntington’s disease is a rare genetic condition that causes nerve cells in the brain to decay over time. ?? The therapeutic field has been riddled with trial failures and abandoned studies. Only yesterday, Sage Therapeutics binned its once-promising Huntington’s program. ??? ?? However, with the EMA’s ongoing review of Prilenia’ pridopidine and recent encouraging results for uniQure’s AMT-130, Wave Life Sciences’ WVE-003, and Roche and Ionis Pharmaceuticals, Inc.’ tominersen, effective treatments seem to be on their way. ??? Read our latest article to find out what treatments are in store to treat the genetic condition! ?? https://lnkd.in/dAi4nyaq #huntingtonsdisease #rarediseases #geneticdisorders #genetictherapies #therapeuticadvances #biotechinnovation #neurologicalresearch
-
Prilenia转发了
Thank you to all of our sponsors for continuing to support the HD community. #letstalkabouthd
-
-
Thank you Huntington's Disease Society of America (HDSA) for all you do in helping to harness the power of the #Huntingtonsdisease community in providing the patient perspective around symptoms and the impact the condition has on their life, and current approaches to treatment. Prilenia is proud to be an active partner in these important efforts.
WHAT A POWERFUL DAY! More than 31 hours ago brave community advocates, friends and family members filed into The Hotel at University of Maryland and joined us online for the opportunity to speak to the FDA at yesterday’s EL-PFDD Meeting. Each and every member showed up and raised their voices to provide insight into what is needed by our community. To everyone, who joined us in-person, participated in the surveys, jumped online to listen and wrote in to submit answers, THANK YOU! #HDSA #NYA #ELPFDDMeeting #LetTalkAboutHD #FamilyIsEverything
-
-
Meet Brianna. She is sharing her family’s story to bring greater understanding of #Huntingtonsdisease and more research into treatment options.? Learn more about Brianna and her family at: https://lnkd.in/dp2qc3bt
-
-
Congratulations to Huntington Study Group and the entire HD community on a fantastic and busy #HSG2024 meeting! It was a busy couple of days for Prilenia too, with 5 posters (which can be seen here: https://lnkd.in/dvDqgv24), an oral presentation, a panel appearance on Family Day and loads of activity at our exhibition table.
-
-
Prilenia is delighted to have been able to help make this important Scottish Huntington's Association event happen for the HD community in Scotland!
A huge thank you to everyone who attended today’s 35th Anniversary Family Gathering - it has been an honour celebrating this milestone with you all. A special thank you to our amazing sponsors who made this event possible: Prilenia uniQure Wave Life Sciences Your support means the world to us. Here’s to many more years of connection, community, and shared memories.
-
-
Wonderful to see many from the HD community coming together, to further understand the research progress being made, at the Huntington Study Group Family day! Prilenia’s Seth Rotberg, MNM will be there connecting with as many people as possible.
??It's HSG 2024 Family Day!?? We're so excited and honored to welcome the HD community to today's event. ??We hope everyone leaves today's sessions feeling inspired, connected, with a better understanding of HD research, and full of hope for the future. ??From the bottom of our hearts, thank you to all of our attendees, event sponsors, exhibitors, and the University of Cincinnati team for their warm welcome and support of this event. #HSG2024 #FamilyDay #HD #Community
-
-
-
-
-
+5
-
-
Today is the start of Huntington Study Group 2024! Prilenia has plenty of #pridopidine data to talk about, and we have a stellar team in attendance who would love to chat. Come say hi at exhibit table #4.
-
-
Prilenia转发了
?? New Webinar Video Available! Our latest webinar, “Research Insights: Latest Updates on Ongoing Studies,” is now available on our website and YouTube channel! Professor ?sa Petersén and experts from Prilenia, uniQure, PTC Therapeutics, Inc. and Wave Life Sciences shared exciting updates on clinical trials for Huntington’s disease. ?Catch up on the latest research insights and Q&A session here ? https://bit.ly/4e8mA2H #HuntingtonsDisease #ClinicalTrials #EHAWebinar #ResearchUpdates
-